The marketing authorisation for this product has been withdrawn at the request of the marketing authorisation holder.
Yarvitan : EPAR - Summary for the public (PDF/255.16 KB)
First published: 04/09/2007
Last updated: 04/09/2007
|Agency product number||
|International non-proprietary name (INN) or common name||
|Anatomical therapeutic chemical veterinary (ATCvet) codes||
Janssen Pharmaceutica N.V.
|Date of issue of marketing authorisation valid throughout the European Union||
20/10/2008 Yarvitan - EMEA/V/C/000113 - II/0003
- Annex I - Summary of product characteristics
- Annex IIA - Manufacturing-authorisation holder responsible for batch release
- Annex IIB - Conditions of the marketing authorisation
- Annex IIIA - Labelling
- Annex IIIB - Package leaflet
Please note that the size of the above document can exceed 50 pages.
You are therefore advised to be selective about which sections or pages you wish to print.
Antiobesity preparations, excl. diet products
As an aid in the management of overweight and obesity in adult dogs. To be used as part of an overall weight management programme which also includes appropriate dietary changes. Introducing appropriate lifestyle changes (e.g. increased exercise), in conjunction with this weight management programme, may provide additional benefits.